Related Experiment Video
Updated: Apr 16, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
MiR-129-2 functions as a tumor suppressor in glioma cells by targeting HMGB1 and is down-regulated by DNA methylation
Yu Yang1, Jun-Qiang Huang, Xi Zhang
1Department of Oncology, Xiangya Hospital, Central South University, Changsha, 410008, Hunan, China.
Abstract:
MicroRNA (miRNA) dysregulation is causally related to cancer development and progression, and recent reports have revealed that DNA methylation constitutes an important mechanism for miRNA deregulation in cancer. MiR-129-2 has been reported to be down-regulated and functions as a tumor suppressor in a few human cancers. However, the involvement of miR-129-2 in the pathology of glioma and the mechanism underlying miR-129-2 regulation in glioma cells remain unclear. In this study, we performed quantitative PCR to investigate the level of miR-129-2 in 21 pairs of glioma tumors and matched adjacent tissues and found that miR-129-2 is down-regulated in glioma tumors. In vitro cell growth, apoptosis, cell migration, and invasion assays revealed that miR-129-2 functions as a tumor suppressor in glioma cells. Luciferase reporter assay found that miR-129-2 could directly target high-mobility group box 1 (HMGB1) and inhibit its expression in glioma cells. Methylation-specific PCR found that DNA methylation in upstream regions of miR-129-2 occured more frequently in cancer tissues than in adjacent tissues. Demethylation of miR-129-2 by 5-aza-2'-deoxycytidine treatment and quantitative PCR analysis revealed that miR-129-2 expression is epigenetically regulated in glioma cells. Taken together, our data suggested that miR-129-2 functions as a tumor suppressor in glioma cells by directly targeting HMGB1 and is down-regulated by DNA methylation, which may provide a novel therapeutic strategy for treatment of glioma.
Insights
MicroRNA-129-2 (miR-129-2) acts as a tumor suppressor in glioma by targeting HMGB1. Its expression is reduced in glioma due to DNA methylation, offering a potential therapeutic target.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- MicroRNA (miRNA) dysregulation is linked to cancer development.
- DNA methylation is a key mechanism for miRNA deregulation in cancer.
- MiR-129-2 is a known tumor suppressor, but its role in glioma was unclear.
Purpose of the Study:
- Investigate miR-129-2's role in glioma pathology.
- Determine the regulatory mechanisms of miR-129-2 in glioma cells.
- Explore miR-129-2 as a potential therapeutic target for glioma.
Main Methods:
- Quantitative PCR to measure miR-129-2 levels in glioma tissues.
- In vitro assays (cell growth, apoptosis, migration, invasion) to assess miR-129-2 function.
- Luciferase reporter assay to identify miR-129-2 targets.
- Methylation-specific PCR and demethylation treatment to study epigenetic regulation.
Main Results:
- MiR-129-2 was significantly down-regulated in glioma tumors compared to adjacent tissues.
- Overexpression of miR-129-2 suppressed glioma cell growth, migration, and invasion.
- MiR-129-2 directly targets and inhibits high-mobility group box 1 (HMGB1) expression.
- DNA methylation in miR-129-2 upstream regions was more frequent in glioma tissues, indicating epigenetic regulation.
Conclusions:
- MiR-129-2 functions as a tumor suppressor in glioma by targeting HMGB1.
- Down-regulation of miR-129-2 in glioma is mediated by DNA methylation.
- Epigenetic silencing of miR-129-2 presents a potential therapeutic strategy for glioma treatment.
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

